SKI Market

A+| A| A-|

Indian Indices

Sensex

73,134.32 1,186.77
( 1.65%)

Global Indices

Nasdaq

46,363.90 1,126.75
(2.49%)

Dow Jones

6,550.24 185.52
(2.91%)

Hang Seng

53,589.67 2,525.95
(4.95%)

Nikkei 225

10,364.79 188.34
(1.85%)

Forex

USD-INR

94.31 -0.22
(-0.23%)

EUR-INR

108.30 -0.48
(-0.44%)

GBP-INR

124.69 -0.63
(-0.50%)

JPY-INR

0.59 0.00
(0.19%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Glenmark Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

532296

INE935A01035

848.3143291

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

GLENMARK

40.58

60201.9

EPS(TTM)

Face Value()

Div & Yield %

52.57

0.12

Back

awl agri business ltd

HMT reports consolidated net loss of Rs 39.08 crore in the September 2025 quarter

Nov 14,2025

Net Loss of HMT reported to Rs 39.08 crore in the quarter ended September 2025 as against net loss of Rs 27.09 crore during the previous quarter ended September 2024. Sales declined 37.89% to Rs 25.83 crore in the quarter ended September 2025 as against Rs 41.59 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	25.83	41.59	-38
OPM %	-145.10	-55.16	-
PBDT	-37.27	-25.48	-46
PBT	-39.08	-27.09	-44
NP	-39.08	-27.09	-44

73,134.32 1,186.77 ( 1.65%)

46,363.90 1,126.75 (2.49%)

6,550.24 185.52 (2.91%)

53,589.67 2,525.95 (4.95%)

10,364.79 188.34 (1.85%)

94.31 -0.22 (-0.23%)

108.30 -0.48 (-0.44%)

124.69 -0.63 (-0.50%)

0.59 0.00 (0.19%)